Greten et al. investigated a multi-peptide vaccine (GV1001) utilizing HCC-associated antigens, including alpha-fetoprotein (AFP), human telomerase reverses transcriptase (hTERT), and melanoma-associated gene-A1 (MAGE-A1). The gene discussed is AFP; the disease is hepatocellular carcinoma.